Correlation Between NYSE Composite and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Atea Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Atea Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Atea Pharmaceuticals
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and Atea is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Atea Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.34 times more return on investment than Atea Pharmaceuticals. However, NYSE Composite is 2.98 times less risky than Atea Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 1,907,793 in NYSE Composite on December 28, 2024 and sell it today you would earn a total of 19,237 from holding NYSE Composite or generate 1.01% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Atea Pharmaceuticals
Performance |
Timeline |
NYSE Composite and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Atea Pharmaceuticals
Pair trading matchups for Atea Pharmaceuticals
Pair Trading with NYSE Composite and Atea Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.NYSE Composite vs. Melco Resorts Entertainment | NYSE Composite vs. SLR Investment Corp | NYSE Composite vs. Stepstone Group | NYSE Composite vs. Greentown Management Holdings |
Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |